Zoledronic acid delays the onset of skeletal-related events and progression of skeletal disease in patients with advanced renal cell carcinoma

Allan Lipton, Ming Zheng, John Seaman

Research output: Contribution to journalArticlepeer-review

195 Scopus citations

Fingerprint Dive into the research topics of 'Zoledronic acid delays the onset of skeletal-related events and progression of skeletal disease in patients with advanced renal cell carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences